Early Application of Continuous Positive Airway Pressure in Coronavirus Patients at Risk of Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Covid19Obstructive Sleep ApneaCPAP VentilationCorona Virus Infection
Interventions
DEVICE

CPAP ( Continuous positive airway pressure)

The enrolled eighty patients were simply randomized into two equal groups: Non-CPAP group and CPAP group using a computer-generated table of random numbers. The group allocation was concealed in sequentially numbered, sealed, and opaque envelopes. Patients were selected from isolation center in Mansoura University hospital,Non-CPAP group will receive medical treatment plus oxygen therapy according to recommendation of protocol of the Egyptian Ministry of Health 2020 and CPAP group as in Non-CPAP group plus using CPAP.

DEVICE

oxygen therapy

both groups will receive oxygen

Trial Locations (1)

35511

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT05934916 - Early Application of Continuous Positive Airway Pressure in Coronavirus Patients at Risk of Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter